US Supreme Court rules telehealth abortion can resume while lawsuit continues

The U.S. Supreme Court ruled that telehealth access to abortion medication mifepristone can continue under current FDA rules until the 5th Circuit Court of Appeals decides the case Louisiana v. Food and Drug Administration. Justices Samuel Alito and Clarence Thomas dissented, citing the Comstock Act and concerns about irreparable harm. The decision follows a 10-day stay issued after Louisiana officials challenged the FDA's telehealth access rule.